Russell Investments Group, Ltd. Inovio Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$7.16 - $9.69 $69,172 - $93,615	-9,661 Reduced 31.72%	20,800 $148,000
Q1 2021 May 10, 2021	BUY	$8.81 - $16.96 $73,739 - $141,955	8,370 Added 37.89%	30,461 $282,000
Q4 2020 Feb 08, 2021	SELL	$8.5 - $12.85 $82,118 - $124,143	-9,661 Reduced 30.43%	22,091 $195,000
Q3 2020 Nov 09, 2020	BUY	$9.57 - $27.05 $211,410 - $597,561	22,091 Added 228.66%	31,752 $367,000
Q2 2020 Aug 05, 2020	BUY	$7.14 - $31.69 $68,979 - $306,157	9,661 New	9,661 $260,000
Q1 2018 May 11, 2018	SELL	$4.05 - $5.69 $76,281 - $107,171	-18,835 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$5.36 - $6.37 $100,955 - $119,978	18,835	18,835 $119,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.